1. Amarillo E, Navarro A, Hernández-García E, et al. Intratympanic steroids for combined treatment of idiopathic sudden hearing loss: when is it too late? Acta Oto-Laryngol. 2019,139(7):632-635. doi:10.1080/00016489.2019.1614222
2. Covelli E, Altabaa K, Verillaud B. Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2018,138(11):966-971. doi:10.1080/00016489.2018.1497805
3. Huafeng Y, Hongqin W, Wenna Z, et al. Clinical characteristics and prognosis of elderly patients with idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2019,139(10):866-869. doi:10.1080/00016489.201.1641218
4. Zhang Y, Jiang Q, Wu X, et al. The influence of metabolic syndrome on the prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2019,40(8):994-997. doi:10.1097/MAO.0000000000002352
5. Chen C, Wang M, Wang H, et al. Impact of hyperlipidemia as a coexisting factor on the prognosis of idiopathic sudden sensorineural hearing loss: a propensity score matching analysis. Clin Otolaryngol. 2020,45(1):2-11. doi:10.1111/coa.13421
6. Chung JH, Cho SH, Jeong JH, et al. Multivariate analysis of prognostic factors for idiopathic sudden sensorineu- ral hearing loss in children. Laryngoscope. 2015,125(9):2209-2215. doi:10.1002/lary.25196
7. Chaushu H, Ungar OJ, Abu Eta R, et al. Spontaneous recovery rate of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis. Clin Otolaryngol. 2023,48(3):395-402. doi:10.1111/coa.14036
8. Nonoyama H, Tanigawa T, Shibata R, et al. Red blood cell distribution width predicts prognosis in idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2016,136(11):1137-1140. doi:10.1080/00016489.2016.1195919
9. Kınar A, Ulu S, Bucak A, et al. Can Systemic immune- inflammation index (SII) be a prognostic factor of Bell’s palsy patients?. Neurol Sci. 2021,42(8):3197-3201. doi:10.1007/s10072-020-04921-5
10. Bildirici, M. A., & Kocatürk, İ. Can immature granulocyte (IG), an inflammatory marker, be used in the differential diagnosis of epilepsy and non-epileptic psychogenic seizure?. Kastamonu Med J. 2023,3(3):155-158.
11. Yılmaz U. A New and early marker in the diagnosis of acute complicated appendicitis: immature granulocytes.Ulus Travma Acil Cerrahi Derg. 2018,24(5):434-439.
12. Kaneva AM, Yanov YK, Bojko SG, et al. The atherogenic index (ATH index) as a potential predictive marker of idiopathic sudden sensorineural hearing loss: a case control study. Lipids Health Dis. 2019,18(1):64. doi:10. 1186/s12944-019-1016-5
13. Hiramatsu M, Teranishi M, Uchida Y, et al. Polymorphisms in genes involved in inf- lammatory pathways in patients with sudden sensorineu- ral hearing loss. J Neurogenet. 2012,26(3-4):387-396. doi:10.3109/01677063.2011.652266
14. Chen L, Zhang G, Zhang Z, et al. Neut-rophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss: a systematic re- view and meta-analysis. Medicine. 2018,97(38):e12492.
15. Rauch SD. Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am. 2004,37(5):1061-1074.
16. Masuda M, Kanzaki S, Minami S, et al. Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2012,33(7):1142-1150. doi:10. 1097/MAO.0b013e3182635417
17. Seo YJ, Jeong JH, Choi JY, et al. Neutrophil-to-lympho- cyte ratio and platelet-to-lymphocyte ratio: novel markers for diagnosis and prognosis in patients with idiopathic sudden sensorineural hearing loss. Dis Markers. 2014,2024:702807. doi:10.1155/2014/702807
18. Yu J, Li SM, Kong Y, et al. Association of immune-inflammation index with outcome of high-risk acral melanoma patients treated with adjuvant high dose interferon. J Clin Oncol. 2016,34(15_ suppl):e21070.
19. Lolli C, Basso U, Derosa L, et al. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Oncotarget. 2016,7(4): 54564-54571. doi:10.18632/oncotarget.10515
20. Özler GS. Increased neutrophil-lymphocyte ratio in patients with idiopathic sudden sensorineural hearing loss. J Craniofac Surg. 2014,25(3): e260-e263. doi:10.1097/SCS.0000000000000565
21. Koçak HE, Elbistanlı MS, Acıpayam H, et al. Are neutrophil/ lymphocyte and platelet/lym- phocyte ratios related with formation of sudden hearing loss and its prognosis? Eur Ann Otorhinolaryngol Head Neck Dis. 2017,134(6):383-386. doi:10.1016/j.anorl.2016.06.005
22. Ulu S, Ulu MS, Bucak A, et al. Neut-rophil-to-lymphocyte ratio as a new, quick, and reliable indica- tor for predicting diagnosis and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2013,34(8): 1400-1404. doi:10.1097/MAO.0b013e31829b57df
23. Gupta K, Tyagi AK, Varshney S, et al. Role of blood investigations in idiopathic unilateral sensorineural hearing loss. Indian J Otolaryngol Head Neck Surg. 2022,74(Suppl 3):3682-3686. doi:10.1007/s12070-021-02413-2
24. Ulu Ş, Kınar A, Bucak A, et al. Systemic immune inflammatory index of patients with idiopathic sudden sensorineural hearing loss: comparison of NLR and PRL Values. Ear Nose Throat J. 2021,100(10):726-730. doi:10. 1177/0145561320924312
25. Kumbul YÇ, Yasan H , Tüz M, et al. Prognostic evaluation of systemic immune inflammation index in sudden idiopathic sensorineural hearing loss. SDÜ Tıp Fak Derg. 2020,27(4):455-461.